.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Merck
AstraZeneca
US Department of Justice
Colorcon
McKesson
Teva
Chubb
Julphar
McKinsey

Generated: June 25, 2017

DrugPatentWatch Database Preview

VERMOX Drug Profile

« Back to Dashboard

Which patents cover Vermox, and what generic Vermox alternatives are available?

Vermox is a drug marketed by Janssen Pharms and is included in two NDAs.

The generic ingredient in VERMOX is mebendazole. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mebendazole profile page.

Summary for Tradename: VERMOX

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list81
Clinical Trials: see list4
Patent Applications: see list2,019
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VERMOX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
VERMOX
mebendazole
TABLET, CHEWABLE;ORAL017481-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Janssen Pharms
VERMOX
mebendazole
TABLET, CHEWABLE;ORAL208398-001Oct 19, 2016RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VERMOX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
VERMOX
mebendazole
TABLET, CHEWABLE;ORAL017481-001Approved Prior to Jan 1, 19823,657,267► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Moodys
AstraZeneca
Queensland Health
Baxter
Chubb
Harvard Business School
Federal Trade Commission
Cipla
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot